血液肿瘤患者上肢中心静脉导管相关深静脉血栓后拔管与肺栓塞风险
这项多中心回顾性队列研究纳入626例血液肿瘤合并中心静脉导管相关上肢深静脉血栓患者,比较抗凝治疗下早期(≤48小时)与延迟(>48小时)拔管后7天内肺栓塞风险。抗凝患者中早期拔管组肺栓塞发生率为0.78%,延迟或不拔管组为0.44%(P > .9),早期拔管未增加肺栓塞风险。
要点
- 血液肿瘤合并导管相关上肢深静脉血栓患者中,早期拔管未增加7天内肺栓塞风险。
- 抗凝患者早期拔管组肺栓塞发生率0.78%,延迟或不拔管组0.44%,差异无统计学意义。
- 仅拔管未抗凝患者7天内无肺栓塞发生,但出现3例死亡。
核心结论
- 在血液肿瘤合并中心静脉导管相关上肢深静脉血栓患者中,早期拔管与延迟或不拔管相比未增加肺栓塞风险。
研究设计与样本
- 通过Venous thromboEmbolism Network US在8家机构开展的多中心回顾性队列研究。
- 主要结局为抗凝患者中比较早期(≤48小时)与延迟(>48小时)拔管后7天内客观确认的肺栓塞。
主要发现
- 626例患者中480例接受抗凝治疗,其中255例早期拔管,225例延迟或不拔管;146例未抗凝,其中116例仅拔管。
- 抗凝患者中,早期拔管组7天内肺栓塞2例(0.78%),延迟或不拔管组1例(0.44%)(P > .9)。
- 早期拔管组7天内肺栓塞或任何原因死亡3例(1.18%),延迟或不拔管组3例(1.33%)(P > .9)。
- 仅拔管未抗凝患者中7天内无肺栓塞发生,但出现3例死亡。
临床怎么用
- 对于血液肿瘤合并导管相关上肢深静脉血栓患者,早期拔管(≤48小时)未显示增加肺栓塞风险,可作为临床决策参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Standard treatment of catheter-associated upper extremity deep vein thrombosis (UE-DVT) is anticoagulation, although catheters are often removed for this indication. The optimal time for catheter removal and whether the act and/or timing of catheter removal is associated with pulmonary embolism (PE) remain unknown. A retrospective cohort study was performed at 8 participating institutions through the Venous thromboEmbolism Network US. Patients with hematologic malignancies and central venous catheter (CVC)-associated UE-DVT were included from 1 January 2010 through 31 December 2016. The primary outcome was objectively confirmed PE within 7 days of UE-DVT diagnosis in anticoagulated patients comparing early (≤48 hours) vs delayed (>48 hours) catheter removal. A total of 626 patients were included, among whom 480 were treated with anticoagulation. Among anticoagulated patients, 255 underwent early CVC removal, while 225 had delayed or no CVC removal; 146 patients received no anticoagulation, among whom 116 underwent CVC removal alone. PE within 7 days occurred in 2 patients (0.78%) with early removal compared with 1 patient (0.44%) with delayed or no CVC removal (P > .9). PE or any cause of death within 7 days occurred in 3 patients in both the early removal (1.18%) and delayed/no removal (1.33%) groups (P > .9). In patients treated with CVC removal only (no anticoagulation), there were no PEs but 3 deaths within 7 days. In patients with hematological malignancy and CVC-associated UE-DVT, early removal of CVCs was not associated with an increased risk of PE compared with delayed or no removal.
引用
- Houghton DE, Billett HH, Gaddh M, et al. Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis. Blood Adv. 2021. PMID: 34264267. doi:10.1182/bloodadvances.2021004698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。